Quality prescribing for chronic pain 2026-2029: consultation

23. References

1 International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021 Definitions of Chronic Pain Syndromes - International Association for the Study of Pain (IASP)

2 Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. 3rd ed. Scottish Government; 2018.

3 Royal Pharmaceutical Society, Pharmacy’s Role in Climate Action and Sustainable Healthcare

4 Department of Health and Social Care, Good for you, good for us, good for everybody A plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions, 2021.

5Tennison I, Roschnik S, Ashby B, et al. Health care's response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5(2):e84-e92. doi:10.1016/S2542-5196(20)30271-

6 Bussières A, Hancock MJ, Elklit A, et al. Adverse childhood experience is associated with an increased risk of reporting chronic pain in adulthood: a stystematic review and meta-analysis. Eur J Psychotraumatol. 2023;14(2):2284025. doi:10.1080/20008066.2023.2284025

7 IASP Terminology. 2023.Terminology | International Association for the Study of Pain

8 van Rysewyk S, Blomkvist R, Chuter A, et al. Understanding the lived experience of chronic pain: A systematic review and synthesis of qualitative evidence syntheses. Br J Pain. 2023;17(6):592-605. doi:10.1177/20494637231196426

9 Torrance N, Veluchamy A, Zhou Y, et al. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. Br J Anaesth. 2020;125(2):159-167. doi:10.1016/j.bja.2020.05.017

10 Muller S, Bailey J, Bajpai R, et al. Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study. Pain. 2024;165(10):2282-2290. doi:10.1097/j.pain.0000000000003239

11 Craig, K. D., Holmes, C., Hudspith, M., Moor, G., Moosa-Mitha, M., Varcoe, C., & Wallace, B. (2019). Pain in persons who are marginalized by social conditions. Pain, 161(2)10.1097/j.pain.0000000000001719

12 Macgregor, C., Walumbe, J., Tulle, E., Seenan, C., & Blane, D. N. (2023). Intersectionality as a theoretical framework for researching health inequities in chronic pain. British Journal of Pain, 17(5)10.1177/20494637231188583

13 Scottish Government. (2023). Scottish Health Survey 2022 main report – volume 1.

14 Miall, N., Fergie, G., & Pearce, A., Health Inequalities in Scotland: trends in deaths, health and wellbeing, health behaviours, and health services since 2000. University of Glasgow, 2022. 10.36399/gla.pubs.282637

15 McCartney, G., Popham, F., McMaster, R., et al., Defining health and health inequalities. Public Health, 2019; 172, 22–30. 10.1016/j.puhe.2019.03.023

16 Scottish Intercollegiate Guidelines Network (SIGN), Management of Chronic Pain SIGN 136, 2019.

17 National Institute for Health and Clinical Excellence NG193, Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain 2021

18 National Institute of Health and Care Excellence (NICE), Clinical Knowledge Summaries, Chronic pain, January 2025

19 Faculty of Pain Medicine of the Royal College of Anaesthetists, Core standards for pain management services in the UK, 2021

20 National Institute of Health and Care Excellence (NICE), Clinical Knowledge Summaries, Red flag signs and symptoms, January 2025

21 Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6(3):149-158. doi:10.1016/j.jpain.2004.11.007

22 Cartagena Farias J, Porter L, McManus S, Strang J, Hickman M, Reed K, Smith N. (2017) Prescribing patterns in dependence forming medicines. London: NatCen.

23 Drug-related deaths in Scotland in 2023 - National Records of Scotland (NRS)

24 James J. Dealing with drug-seeking behaviour. Aust Prescr. 2016;39(3):96-100. doi:10.18773/austprescr.2016.022

25 National Institute for Health and Clinical Excellence NG64 Drug misuse prevention: targeted interventions. 2017

26 McCracken LM. Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain. Pain. 1998;74(1):21-27. doi:10.1016/S0304-3959(97)00146-2

27 Chen Y, Sun J, Li Y, Xu W, Du S. Pain Acceptance: A Concept Analysis. Pain Manag Nurs. Published online March 8, 2025. doi:10.1016/j.pmn.2025.02.009

28 Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11(11):CD007407. Published 2012 Nov 14. doi:10.1002/14651858.CD007407.pub3

29 Rosser BA, Fisher E, Janjua S, Eccleston C, Keogh E, Duggan G. Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2023;8(8):CD013863. Published 2023 Aug 29. doi:10.1002/14651858.CD013863.pub2

30 Hilton L, Hempel S, Ewing BA, Apaydin E, Xenakis L, Newberry S, Colaiaco B, Maher AR, Shanman RM, Sorbero ME, Maglione MA. Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Ann Behav Med. 2017 Apr;51(2):199-213. doi: 10.1007/s12160-016-9844-2. PMID: 27658913; PMCID: PMC5368208.

31 Skelly AC, Chou R, Dettori JR, et al. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update. Rockville (MD): Agency for Healthcare Research and Quality (US); April 2020.

32 Franqueiro AR, Yoon J, Crago MA, Curiel M, Wilson JM. The Interconnection Between Social Support and Emotional Distress Among Individuals with Chronic Pain: A Narrative Review. Psychol Res Behav Manag. 2023 Oct 27;16:4389-4399.

33 Whibley D, AlKandari N, Kristensen K, et al. Sleep and Pain: A Systematic Review of Studies of Mediation. Clin J Pain. 2019;35(6):544-558. doi:10.1097/AJP.0000000000000697

34 Mork PJ, Nilsen TI. Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway. Arthritis Rheum. 2012;64(1):281-284. doi:10.1002/art.33346

35 Whale K, Dennis J, Wylde V, Beswick A, Gooberman-Hill R. The effectiveness of non-pharmacological sleep interventions for people with chronic pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022;23(1):440. Published 2022 May 11. doi:10.1186/s12891-022-05318-5

36 de Zoete RM, Armfield NR, McAuley JH, Chen K, Sterling M. Comparative effectiveness of physical exercise interventions for chronic non-specific neck pain: a systematic review with network meta-analysis of 40 randomised controlled trials. Br J Sports Med. Published online November 2, 2020. doi:10.1136/bjsports-2020-102664

37 Brain K, Burrows TL, Rollo ME, et al. A systematic review and meta-analysis of nutrition interventions for chronic noncancer pain. J Hum Nutr Diet. 2019;32(2):198-225. doi:10.1111/jhn.12601

38 Gregori D, Giacovelli G, Minto C, Barbetta B, Gualtieri F, Azzolina D, et al. Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. Jama. 2018;320(24):2564-79.

39 Wilson MV, Braithwaite FA, Arnold JB, et al. The effectiveness of peer support interventions for community-dwelling adults with chronic musculoskeletal pain: a systematic review and meta-analysis of randomised trials. Pain. 2024;165(12):2698-2720. doi:10.1097/j.pain.0000000000003293

40 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update, 2020 Opioids: risk of dependence and addiction

41 Public Health England, 2019. Dependence and withdrawal associated with some prescribed medicines. London [online]

42 Derry, S., Bell, R.F., Straube, S., Wiffen, P.J., Aldington, D. and Moore, R.A., 2019. Pregabalin for neuropathic pain in adults. Cochrane Database of Systematic Reviews, (1).

43 National Institute for Health and Care Excellence (NICE) Low back pain and sciatica in over 16s: assessment and management [NG59] 2020

44 McDonagh MS, Selph SS, Buckley DI, et al. Nonopioid pharmacologic treatments for chronic pain. Rockville (MD): Agency for Healthcare Research and Quality (US); April 2020.

45 National Institute for Health and Care Excellence (NICE) Osteoarthritis in over 16s: diagnosis and management October 2022

46 Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552-559. doi:10.1136/annrheumdis-2014-206914

47 British National Formulary 2025

48 British National Formulary Treatment Summary: Non-steroidal anti-inflammatory drugs

49 Richards, D. The Oxford Pain Group League table of analgesic efficacy. Evid Based Dent 5, 22–23 (2004). https://doi.org/10.1038/sj.ebd.6400237

50 Derry, S., Wiffen, P.J., Häuser, W., Mücke, M., Tölle, T.R., Bell, R.F. and Moore, R.A., 2017. Oral nonsteroidal anti‐inflammatory drugs for fibromyalgia in adults. Cochrane Database of Systematic Reviews, (3).

51 Korownyk, C.S., Montgomery, L., Young, J., Moore, S., Singer, A.G., MacDougall, P., Darling, S., Ellis, K., Myers, J., Rochford, C. and Taillefer, M.C., 2022. PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care. Canadian Family Physician, 68(3), pp.179-190

52 Cashin, A.G., Wand, B.M., O'Connell, N.E., Lee, H., Rizzo, R.R., Bagg, M.K., O'Hagan, E., Maher, C.G., Furlan, A.D., van Tulder, M.W. and McAuley, J.H., 2023. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews, (4).

53 Wiffen PJ, Xia J. Systematic review of topical diclofenac for the treatment of acute and chronic musculoskeletal pain. Current medical research and opinion 2020;36(4):637-50.

54 AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023; 71(7): 2052-2081. doi:10.1111/jgs.18372

55 Specialist Pharmacy Service Using NSAIDs in asthma July 2024

56 Nury, E., Schmucker, C., Nagavci, B., Motschall, E., Nitschke, K., Schulte, E., Wegwarth, O. and Meerpohl, J.J., Efficacy and safety of strong opioids for chronic noncancer pain and chronic low back pain: a systematic review and meta-analyses. Pain, 2022;163(4), pp.610-636.

57 Petzke, F., Klose, P., Welsch, P., Sommer, C. and Häuser, W., Opioids for chronic low back pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks of double‐blind duration. European Journal of Pain, 2020; 24(3), pp.497-517.

58 Chou R, Hartung D, Turner J, Blazina I, Chan B, Levander X, et al. Opioid Treatments for Chronic Pain. Agency for Healthcare Research and Quality 2020:04

59 Noori A, Sadeghirad B, Wang L, Siemieniuk R.A.C., Shokoohi M, Kum E, et al. Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. British Journal of Anaesthesia 2022;129:394-406.

60 Chou R, Selph S, Wagner J, Ahmed A.Y., Jungbauer R, Mauer K, et al. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1. Rockville, MD: Agency for Healthcare Research and Quality; 2022.

61 Chou R, Selph S, Wagner J, Ahmed A.Y., Jungbauer R, Mauer K, et al. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2. Rockville, MD: Agency for Healthcare Research and Quality; 2022.

62 Chou R, Selph S, Wagner J, Ahmed AY, Jungbauer R, Mauer K, et al. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 3. Rockville, MD: Agency for Healthcare Research and Quality; 2022.

63 Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022;71(3):1-95

64 Faculty of Pain Medicine, Opioids Aware

65 Jani M, Girard N, Bates DW, Buckeridge DL, Dixon WG, Tamblyn R. Comparative risk of mortality in new users of prescription opioids for noncancer pain: results from the International Pharmacosurveillance Study. Pain 2024.

66 Bedson J, Chen Y, Ashworth J, Hayward RA, Dunn KM, Jordan KP. Risk of adverse events in patients prescribed long-term opioids: A cohort study in the UK Clinical Practice Research Datalink. Eur J Pain 2019;23(5):908-22.

67 NHS Inform, Chronic Pain

68 Mattia C, Luongo L, Innamorato M, Melis L, Sofia M, Zappi L and Puntillo F. An Italian expert consensus on the use of opioids for the management of chronic non-oncological pain in clinical practice: focus on buprenorphine. Journal of Pain Research. 2021;14(3193-3206.

69 Elmoheen, A., Nazal, A.F., Zubaidi, O., Siddiqui, U.A. and Alhatou, M., 2021. Expert review and recommendations for the management of acute, chronic, and neuropathic pain in Qatar. Qatar Medical Journal, 2021(2), p.19.

70 Nagar V.R., Birthi P, Salles S, Sloan P.A., Opioid Use in Chronic Pain Patients with Chronic Kidney Disease: A Systematic Review. Pain medicine (Malden, Mass) 2017;18:1416–49

71 Chou, R., Turner, J.A., Devine, E.B., Hansen, R.N., Sullivan, S.D., Blazina, I., Dana, T., Bougatsos, C. and Deyo, R.A., 2015. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Annals of internal medicine, 162(4), pp.276-286.

72 Colvin, L.A. and Fallon, M.T., 2010. Opioid-induced hyperalgesia: a clinical challenge. British journal of anaesthesia, 104(2), pp.125-127.

73 Daniell, H.W., 2002. Hypogonadism in men consuming sustained-action oral opioids. The Journal of Pain, 3(5), pp.377-384.

74 Daniell, H.W., 2008. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. The Journal of Pain, 9(1), pp.28-36.

75 Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression - GOV.UK

76 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update 2017. Gabapentin (Neurontin): risk of severe respiratory depression.

77 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update, 2021. Pregabalin (Lyrica)): reports of severe respiratory depression.

78 FDA drug safety communication, 2020

79 Birkinshaw H, Friedrich CM, Cole P, Eccleston C, Serfaty M, Stewart G, et al. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database of Systematic Reviews 2023;5:CD014682.

80 Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia. Cochrane Database of Systematic Reviews 2018(2).

81 Fenske, J.N., Berland, D.W., Chandran, S., Van Harrison, R., Schneiderhan, J., Hilliard, P.E., Bialik, K.C., Clauw, D.J., Lowe, D.A., Mehari, K.S. and Smith, M.A. Ambulatory Pain Management Guideline 2021, University of Michigan

82 Mair A, Fernandez-Limos F, Alonso A, Harrison C, Hurding S, et al. Polypharmacy Management by 2030: a patient safety challenge, 2nd Edition. Coimbra: SIMPATHY Consortium, 2017.

83 Migliorini F, Maffulli N, Eschweiler J, Betsch M, Catalano G, Driessen A, Tingart M and Baroncini A. The pharmacological management of chronic lower back pain. Expert opinion on pharmacotherapy. 2021;22(1):109-119.

84 Scottish Government Quality prescribing for antidepressants: guide for improvement 2024 to 2027 - gov.scot

85 Taylor, D.M., Barnes, T.R. and Young, A.H., 2021. The Maudsley prescribing guidelines in psychiatry. John Wiley & Sons.

86 Enke, O., New, H.A., New, C.H., Mathieson, S., McLachlan, A.J., Latimer, J., Maher, C.G. and Lin, C.W.C., 2018. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. Cmaj, 190(26), pp.E786-E793.

87 Centre for Clinical Practice at NICE (UK, 2013. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings [Internet]. Updated 2020

88 Moore, R.A., Wiffen, P.J., Derry, S. and Rice, A.S., 2014. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane database of systematic reviews, (4).

89 Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD005451. DOI: 10.1002/14651858.CD005451.pub3. Accessed 21 May 2025.

90 UK Government, Medicines and Healthcare Products Regulatory Agency, Drug Safety Update, 2021. Pregabalin (Lyrica): findings of safety study on risks during pregnancy.

91 Falk, J., Thomas, B., Kirkwood, J., Korownyk, C.S., Lindblad, A.J., Ton, J., Moe, S., Allan, G.M., McCormack, J., Garrison, S. and Dugré, N., 2021. PEER systematic review of randomized controlled trials: Management of chronic neuropathic pain in primary care. Canadian Family Physician, 67(5), pp.e130-e140. available at: PEER systematic review of randomized controlled trials | The College of Family Physicians of Canada

92 Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1(1):CD007393. Published 2017 Jan 13. doi:10.1002/14651858.CD007393.pub4

93 Specialist Pharmacy Service: Use of nefopam for chronic pain, January 2024

94 Richards BL, Whittle SL, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012;1(1):CD008921. Published 2012 Jan 18. doi:10.1002/14651858.CD008921.pub2

95 Stockings E, Campbell G, Hall WD, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018 Oct;159(10):1932-1954. DOI: 10.1097/j.pain.0000000000001293. PM

96 Dykukha I, Malessa R, Essner U, Überall MA. Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials. Pain Medicine. 2021;22(4):861-74.

97 Johal H, Devji T, Chang Y, Simone J, Vannabouathong C, Bhandari M. Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2020;13:1179544120906461.

98 McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, et al. Cannabis-based products for chronic pain: a systematic review. Annals of internal medicine. 2022;175(8):1143-53.

99 McParland AL, Bhatia A, Matelski J, Tian C, Diep C, Clarke H, et al. Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. Regional Anesthesia & Pain Medicine. 2023;48(4):180-90.

100 Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis‐based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews. 2018(3).

101 Wang L, Hong PJ, May C, Rehman Y, Oparin Y, Hong CJ, et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021;374.

102 IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement. PAIN 162():p S1-S2, July 2021.

103 British Pain Society Position statement on the medicinal use of cannabinoids in pain management October 2018

104 Wong SSC, Chan WS, Cheung CW. Analgesic effects of cannabinoids for chronic non-cancer pain: a systematic review and meta-analysis with meta-regression. Journal of Neuroimmune Pharmacology. 2020;15:801-29.

105 Chou, R., Ahmed, A.Y., Dana, T., Morasco, B.J., Bougatsos, C., Fu, R., Williams, L. and Ivlev, I., 2024. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update

106 National Records of Scotland 2024. Drug-related deaths in Scotland in 2023.

107 Lu, C.B., Liu, P.F., Zhou, Y.S., Meng, F.C., Qiao, T.Y., Yang, X.J., Li, X.Y., Xue, Q., Xu, H., Liu, Y. and Han, Y., 2020. Musculoskeletal pain during the menopausal transition: A systematic review and meta‐analysis. Neural plasticity, 2020(1), p.8842110.

108 Oxford University Hospitals Pain Management Centre, Guidance for opioid reduction in primary care, October 2023

109 Audi S, Burrage DR, Lonsdale DO, et al. The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers. Br J Clin Pharmacol. 2018;84(11):2562-2571. doi:10.1111/bcp.13709

110 Levy N, Lord LJ, Lobo DN. UK recommendations on opioid stewardship. BMJ. 2021;372:m4901. Published 2021 Jan 5. doi:10.1136/bmj.m4901

111 Simpson AK, Levy N, Mariano ER. Opioid stewardship. BJA Educ. 2023;23(10):389-397. doi:10.1016/j.bjae.2023.05.007

112 Shrestha S, Khatiwada AP, Sapkota B, et al. What is "Opioid Stewardship"? An Overview of Current Definitions and Proposal for a Universally Acceptable Definition. J Pain Res. 2023;16:383-394. Published 2023 Feb 10. doi:10.2147/JPR.S389358

113 El-Boghdadly K, Levy NA, Fawcett WJ, et al. Peri-operative pain management in adults: a multidisciplinary consensus statement from the Association of Anaesthetists and the British Pain Society. Anaesthesia. 2024;79(11):1220-1236. doi:10.1111/anae.16391

114 Faculty of Pain Medicine: Opioids Aware – Patient assessment

115 Right Decision Service Post surgery opioid prescribing (Guidelines) June 2023

116 Hyland, S.J., Brockhaus, K.K., Vincent, W.R., Spence, N.Z., Lucki, M.M., Howkins, M.J. and Cleary, R.K., 2021, March. Perioperative pain management and opioid stewardship: a practical guide. In Healthcare (Vol. 9, No. 3, p. 333). MDPI.available at: Perioperative Pain Management and Opioid Stewardship: A Practical Guide

117 Levy N, Quinlan J, El-Boghdadly K, et al. An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patients. Anaesthesia. 2021;76(4):520-536. doi:10.1111/anae.15262

118 McAnally, H., 2017. Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol. Perioperative medicine, 6(1), p.19. available at:

Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol | Perioperative Medicine

119 Srivastava, D., Hill, S., Carty, S., Rockett, M., Bastable, R., Knaggs, R., Lambert, D., Levy, N., Hughes, J. and Wilkinson, P., 2021. Surgery and opioids: evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom. British Journal of Anaesthesia, 126(6), pp.1208-1216.

available at:Surgery and opioids: evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom - ScienceDirect

120 Faculty of Pain Medicine, Surgery and Opioids: Best Practice Guidelines 2021

121 Public Health Scotland Acute hospital activity and NHS beds information (annual) September 2024

122 OECD/European Commission, Health at a Glance: Europe 2024: State of Health in the EU Cycle, 2024. Paris: OECD Publishing. 10.1787/b3704e14-en.

123 Raymond, A., Watt, T., Douglas, H. R., et al., Health inequalities in 2040. Current and projected patterns of illness by deprivation in England, 2024, The Health Foundation.

124 Lucyk, K., & McLaren, L., Taking stock of the social determinants of health: a scoping review. PLoS ONE, 2017; 12(5), e0177306. 10.1371/journal.pone.0177306

125 McCartney, G., Dickie, E., Escobar, O., & Collins, C., Health inequalities, fundamental causes and power: towards the practice of good theory. Sociology of Health and Illness, 2020; 43(1), 20–39. 10.1111/1467-9566.13181

126 National Institute for Health and Care Excellence, NICE and Health Inequalities, 2024.

127 Krauth, S. J., Steell, L., Ahmed, S., et al., Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts. eClinicalMedicine, 2024; 74, 10.1016/j.eclinm.2024.102703

128 Stannard, S., Holland, E., Crozier, S. R., et al., Early-onset burdensome multimorbidity: an exploratory analysis of sentinel conditions, condition accrual sequence and duration of three long-term conditions using the 1970 British Cohort Study. BMJ. 2022; 10.1136/bmjopen-2021-059587

129 Roberts, A., & Richards, G. C., Is England facing an opioid epidemic? British Journal of Pain, 2023; 17(3)10.1177/20494637231160684

130 Torrance, N., Veluchamy, A., Zhou, Y., et al., Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. British Journal of Anaesthesia, 2020; 125(2), 159. 10.1016/j.bja.2020.05.017

131 Woodward, A., Davies, N., Walters, K., et al., Self-management of multiple long-term conditions: A systematic review of the barriers and facilitators amongst people experiencing socioeconomic deprivation. PloS One, 2023; 18(2), e0282036. 10.1371/journal.pone.0282036

132 Craig, K. D., Holmes, C., Hudspith, M., et al., Pain in persons who are marginalized by social conditions. Pain, 2019; 161(2)10.1097/j.pain.0000000000001719

133 Macgregor, C., Walumbe, J., Tulle, E., et al., Intersectionality as a theoretical framework for researching health inequities in chronic pain. British Journal of Pain, 2023; 17(5)10.1177/20494637231188583

134 Scottish Government, Scottish Health Survey 2022 main report – volume 1, 2023.

135 Public Health England, Chronic pain in adults 2017. Health survey for England, 2020.

136 Fayaz, A., Croft, P., Langford, R. M., et al., Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open, 2016; 6(6), e010364. 10.1136/bmjopen-2015-010364

137 Keogh, E., The gender context of pain. Health Psychology Review, 2021; 15(3), 454–481. 10.1080/17437199.2020.1813602

138 Gatchel, R. J., Peng, Y. B., Peters, M. L., et al., The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychological Bulletin, 2007; 133(4), 581. 10.1037/0033-2909.133.4.581

139 Pincus, T., Kim Burton, A., Vogel, S., and Field, A. P., A Systematic Review of Psychological Factors as Predictors of Chronicity/Disability in Prospective Cohorts of Low Back Pain. SPINE, 2002; 27(5)10.1097/00007632-200203010-00017

140 Hughes, K., Bellis, M. A., Hardcastle, K. A., et al., The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis. Lancet Public Health, 2017; 2, e356–e366.

141 Allen, J., Balfour, R., Bell, R., and Marmot, M., Social determinants of mental health. International Review of Psychiatry, 2014; 26(4), 392–407. 10.3109/09540261.2014.928270

142 Doebl, S., Macfarlane, G. J., and Hollick, R. J., “No one wants to look after the fibro patient”. Understanding models, and patient perspectives, of care for fibromyalgia: reviews of current evidence. Pain, 2020; 161(8)10.1097/j.pain.0000000000001870

143 Macgregor, C., Blane, D. N., Tulle, E., et al., An ecosystem of accepting life with chronic pain: A meta-ethnography. British Journal of Pain, 2024; 18(4)10.1177/20494637241250271

144 Toye, F., Seers, K., Allcock, N., et al., Patients’ experiences of chronic non-malignant musculoskeletal pain: a qualitative systematic review. British Journal of General Practice, 2013; 63(617), e829. 10.3399/bjgp13x675412

145 Cheetham, M., Moffatt, S., Addison, M., and Wiseman, A., Impact of Universal Credit in North East England: a qualitative study of claimants and support staff. BMJ. 2019; 10.1136/bmjopen-2019-029611

146 Morgan, C. L., Conway, P., and Currie, C. J., The relationship between self‐reported severe pain and measures of socio‐economic disadvantage. European Journal of Pain, 2011; 15(10), 1107. 10.1016/j.ejpain.2011.04.010

147 Farmer, C., Fenu, E., O’flynn, N., and Guthrie, B., Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016; 10.1136/bmj.i4843

148 May, C. R., Eton, D. T., Boehmer, K., et al., Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Services Research, 2014; 14(1), 281. 10.1186/1472-6963-14-281

149 Smith, J. A., and Osborn, M., Pain as an assault on the self: An interpretative phenomenological analysis of the psychological impact of chronic benign low back pain. Psychology and Health, 2007; 22(5), 517. 10.1080/14768320600941756

150 Webster, F., Connoy, L., Sud, A., et al., (2023). Chronic struggle: an institutional ethnography chronic pain and marginalization. The Journal of Pain, 24(3), 437–448. 10.1016/j.jpain.2022.10.004

151 Blane, D., Lunan, C., Bogie, J., et al., Tackling the inverse care law in Scottish General Practice Policies, interventions and the Scottish Deep End Project. University of Glasgow, University of Edinburgh, 2024.

152 Jain, S., Jadwani, V., Spogmy, S., and Walumbe, J. Inequalities and inequities in the types of chronic pain services available in areas of differing deprivation across England. Scandinavian Journal of Pain, 2022; 23(1), 168–174. 10.1515/sjpain-2022-0015

153 Moore, F. R., Williams, L., and Dunbar, M., Sociodemographic predictors of attendance at a Scottish pain management programme. British Journal of Pain, 2021; 15(4), 393–400. 10.1177/2049463720970579

154 Dixon-Woods, M., Cavers, D., Agarwal, S., et al., Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Medical Research Methodology, 2006; 6(1), 35. 10.1186/1471-2288-6-35

155 Robertson, R., Blythe, N., and Jeffries, D. Tackling health inequalities on NHS waiting lists, 2023, The Kings Fund.

156 Arthritis and Musculoskeletal Alliance. Act Now: Musculoskeletal Health Inequalities and Deprivation, 2024.

157 Gkiouleka, A., Wong, G., Sowden, S., et al., Reducing health inequalities through general practice: a realist review and action framework. Health and Social Care Delivery Research, 2024; 12(7)10.3310/ytww7032

158 Metzl, J. M., and Hansen, H., Structural competency: Theorizing a new medical engagement with stigma and inequality. Social Science and Medicine, 2013; 103, 126. 10.1016/j.socscimed.2013.06.032

159 Laskawska, M. S., Hébert, H. L., Richardson, C., et al., The core minimum dataset for measuring pain outcomes in pain services across Scotland. Developing and testing a brief multi-dimensional questionnaire. British Journal of Pain, 2022; 16(5), 504–517. 10.1177/20494637221092907

160 Lunn, A. D., Lynch, H., Bilaal, A., et al., What works: Addressing inequalities in the primary and secondary outpatient interface, Health Equity Centre, 2024.

161 Baker, R., Freeman, G. K., Haggerty, J. L., et al., Primary medical care continuity and patient mortality: a systematic review. British Journal of General Practice, 2020; 70(698), e600. 10.3399/bjgp20x712289

162 Palmer, W., Hemmings, N., Rosen, R., et al., Improving access and continuity in general practice Evidence review, 2018, Nuffield Trust.

163 Dickie, E., Hearty, W., Fraser, A., et al., Power – a health and social justice issue, 2015. Edinburgh: NHS Scotland.

164 Protheroe, J., Brooks, H., Chew-Graham, C., et al., ‘Permission to participate?’ A qualitative study of participation in patients from differing socio-economic backgrounds. Journal of Health Psychology, 2012; 18(8)10.1177/1359105312459876

165 Brady, B., Veljanova, I., & Chipchase, L., An exploration of the experience of pain among culturally diverse migrant communities. Rheumatology Advances in Practice, 2017; 1(1), rkx002. 10.1093/rap/rkx002

166 Brady, B., Veljanova, I., & Chipchase, L., The Intersections of Chronic Noncancer Pain: Culturally Diverse Perspectives on Disease Burden. Pain Medicine, 2019; 20(3), 434–445. 10.1093/pm/pny088s

167 Browne, A. J., Varcoe, C., Ford-Gilboe, M., et al., Disruption as opportunity: Impacts of an organizational health equity intervention in primary care clinics. International Journal for Equity in Health, 2018; 17(1)10.1186/s12939-018-0820-2

168 Walters, R., Leslie, S. J., Polson, R., et al., Establishing the efficacy of interventions to improve health literacy and health behaviours: a systematic review. BMC Public Health, 2020; 20(1)10.1186/s12889-020-08991-0

169 World Health Organisation, Health Literacy, 2024.

170 Brady, B., Andary, T., Pang, S. M., et al., A Mixed-Methods Investigation into Patients’ Decisions to Attend an Emergency Department for Chronic Pain. Pain Medicine, 2021; 22(10)10.1093/pm/pnab081

171 Lacey, R. J., Campbell, P., Lewis, M., and Protheroe, J., The Impact of Inadequate Health Literacy in a Population with Musculoskeletal Pain. HLRP: Health Literacy Research and Practice, 2018; 2(4)10.3928/24748307-20181101-01

172 Mackey, L. M., Doody, C., Werner, E. L., and Fullen, B., Self-Management Skills in Chronic Disease Management. Medical Decision Making, 2016; 36(6)10.1177/0272989x16638330

173 Mackey, L. M., Blake, C., Casey, M., et al., The impact of health literacy on health outcomes in individuals with chronic pain: a cross-sectional study. Physiotherapy, 2019; 105(3)10.1016/j.physio.2018.11.006

174 NHS England, Health literacy 'how to' guide, 2020.

175 Scottish Government, Making it Easier - a health literacy action plan, 2017.

176 Truong, M., & Fenton, S., Understanding the Current Landscape of Health Literacy Interventions within Health Systems. Perspectives in Health Information Management, 2022; 15(19)PMID: 35692852 PMCID: PMC9123532

177 NHS Education Scotland and Scottish Government, Scottish Psychological Trauma Training Plan, 2019.

178 Substance Abuse and Mental Health Services Administration. SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach, 2014, HHS Publication No. (SMA) 14-4884. RockVille, MD, USA: Substance Abuse and Mental Health Services Administration.

179 Gopal, D. P., Hunter, M., Butler, D., et al., Trauma-informed care: what does it mean for general practice? British Journal of General Practice, 2023; 73(730), 229. 10.3399/bjgp23x732837

180 Purkey, E., Patel, R., and Phillips, S. P., Trauma-informed care: Better care for everyone. Canadian Family Physician, 2018; 64(3), 170–172.

181 Karran, E. L., Cashin, A. G., Barker, T., et al., The ‘what’ and ‘how’ of screening for social needs in healthcare settings: a scoping review. PeerJ, 2023; 11, e15263. 10.7717/peerj.15263

182 Brcic, V., Eberdt, C., and Kaczorowski, J., Development of a Tool to Identify Poverty in a Family Practice Setting: A Pilot Study. International Journal of Family Medicine, 2011, 812182–7. 10.1155/2011/812182

183 Public Health Scotland, Financial Inclusion referral Pathways, 2024.

184 Improvement Service, Welfare Advice and Health Partnerships, 2024.

185 Healthcare Improvement Scotland, The Quality Framework for Community Engagement and Participation, 2023. (last accessed 7 February 2025)

186 Scottish Palliative Care Guidelines Group, Scottish Palliative Care Guidelines, 2019. URL: https://rightdecisions.scot.nhs.uk/scottish-palliative-care-guidelines/

187 World Health Organization Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. 2009.

188 Woody, G.E., Kampman, K.K., Auriacombe, M. (2024). Disorders due to Substance Use: Opioids and Opioid Addiction. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham.

189 Laupacis A., Sackett D., Roberts R., An Assessment of Clinically Useful Measures of the Consequences of Treatment. New England Journal of Medicine. 1988;318(26):1728-1733

190 Cook R., Sackett D., The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310(6977):452-454

191 McAlister, F.A., The “number needed to treat” turns 20—and continues to be used and misused. Cmaj, 2008; 179(6), pp.549-553.

192 Guthrie B., Thompson A., Dumbreck S., et al., Better guidelines for better care: accounting for multimorbidity in clinical guidelines – structured examination of exemplar guidelines and health economic modelling. Health Serv Deliv Res 2017;5(16).